Preventing foot ulcers in patients with diabetes N Singh, DG Armstrong, BA Lipsky Jama 293 (2), 217-228, 2005 | 4744 | 2005 |
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections BA Lipsky, AR Berendt, PB Cornia, JC Pile, EJG Peters, DG Armstrong, ... Clinical infectious diseases 54 (12), e132-e173, 2012 | 2658 | 2012 |
Diagnosis and treatment of diabetic foot infections BA Lipsky, AR Berendt, HG Deery, JM Embil, WS Joseph, AW Karchmer, ... Plastic and reconstructive surgery 117 (7S), 212S-238S, 2006 | 2098 | 2006 |
Risk factors for foot infections in individuals with diabetes LA Lavery, DG Armstrong, RP Wunderlich, MJ Mohler, CS Wendel, ... Diabetes care 29 (6), 1288-1293, 2006 | 1033 | 2006 |
Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update) NC Schaper, JJ van Netten, J Apelqvist, SA Bus, RJ Hinchliffe, BA Lipsky, ... Diabetes/metabolism research and reviews 36, e3266, 2020 | 977 | 2020 |
Chlorhexidine compared with povidone-iodine solution for vascular catheter–site care: a meta-analysis N Chaiyakunapruk, DL Veenstra, BA Lipsky, S Saint Annals of internal medicine 136 (11), 792-801, 2002 | 878 | 2002 |
The burden of diabetic foot ulcers GE Reiber, BA Lipsky, GW Gibbons The American journal of surgery 176 (2), 5S-10S, 1998 | 813 | 1998 |
Oral versus intravenous antibiotics for bone and joint infection HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ... New England Journal of Medicine 380 (5), 425-436, 2019 | 805 | 2019 |
Treatment for diabetic foot ulcers PR Cavanagh, BA Lipsky, AW Bradbury, G Botek The Lancet 366 (9498), 1725-1735, 2005 | 780 | 2005 |
Topical antimicrobial therapy for treating chronic wounds BA Lipsky, C Hoey Clinical infectious diseases 49 (10), 1541-1549, 2009 | 764 | 2009 |
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update) BA Lipsky, É Senneville, ZG Abbas, J Aragón‐Sánchez, M Diggle, ... Diabetes/metabolism research and reviews 36, e3280, 2020 | 748 | 2020 |
IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes BA Lipsky, J Aragón-Sánchez, M Diggle, J Embil, S Kono, L Lavery, ... Diabetes Metab Res Rev 32 (Suppl 1), 45-74, 2016 | 744 | 2016 |
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents DM Citron, EJC Goldstein, CV Merriam, BA Lipsky, MA Abramson Journal of clinical Microbiology 45 (9), 2819-2828, 2007 | 656 | 2007 |
Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents NC Schaper, JJ Van Netten, J Apelqvist, BA Lipsky, K Bakker, ... Diabetes/metabolism research and reviews 32, 7-15, 2016 | 631 | 2016 |
Fluoroquinolone toxicity profiles: a review focusing on newer agents BA Lipsky, CA Baker Clinical Infectious Diseases 28 (2), 352-361, 1999 | 603 | 1999 |
Urinary tract infections in men: epidemiology, pathophysiology, diagnosis, and treatment BA Lipsky Annals of internal medicine 110 (2), 138-150, 1989 | 571 | 1989 |
Osteomyelitis of the foot in diabetic patients BA Lipsky Clinical infectious diseases 25 (6), 1318-1326, 1997 | 557 | 1997 |
Systemic antibiotic therapy for chronic osteomyelitis in adults B Spellberg, BA Lipsky Clinical infectious diseases 54 (3), 393-407, 2012 | 537 | 2012 |
The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence‐based global consensus K Bakker, J Apelqvist, BA Lipsky, JJ Van Netten, NC Schaper, ... Diabetes/metabolism research and reviews 32, 2-6, 2016 | 517 | 2016 |
Validation of the Infectious Diseases Society of America's diabetic foot infection classification system LA Lavery, DG Armstrong, DP Murdoch, EJG Peters, BA Lipsky Clinical infectious diseases 44 (4), 562-565, 2007 | 499 | 2007 |